GNPX is on Full-on 52 Week BREAKOUT Alert! Could Multiple BUY Ratings send this FDA Approval Play to New Highs?

With a SCORCHING chart, Multiple “Buy” Ratings & Wall Street Journal price target of 8.00 – GNPX could be the most Epic FDA Decision Play yet!